Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Professionals should be prepared to whistle-blow or risk investigation

By News team

Health regulators should send a clear signal to professionals that they may be investigated if they fail to raise concerns about colleagues, MPs have indicated. That view is supported by the General Pharmaceutical Council.

Stephen Dorrell, MP, chairman of the Health Committee, said doctors and nurses have an obligation as professionals to raise concerns about the quality of care being delivered by their colleagues. He called on the General Medical Council and the Nursing and Midwifery Council to ensure that failure to act is regarded as a “serious breach of professional obligation”.

However, MPs on the committee recognised that those who have raised concerns are sometimes subject to suspension, dismissal and other sanctions, and have pledged to examine this issue in more detail.

The recommendations have been welcomed by the GPhC. A spokesman highlighted that pharmacists have a duty under GPhC standards to raise concerns not just about fellow registrants but also about other healthcare professionals.

He said: “We are committed to ensuring that pharmacy professionals understand the importance of raising concerns to ensure continued safe and appropriate care of patients and the public.”

However, Royal Pharmaceutical Society spokesman Neal Patel stressed that employers should actively promote the opportunity for pharmacists to feedback on issues that are in the public interest without fear of reprisal.

Earlier this month the RPS brought together regulators, employers and unions to ensure a joined up response to raising concerns for all those in the sector. It will be providing guidance to members on how to report concerns at work in due course.

Citation: The Pharmaceutical Journal URI: 11081317

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now
  • BNF for Children (BNFC) 2019-2020

    BNF for Children (BNFC) 2019-2020

    The BNFC contains essential practical information for all healthcare professionals involved in prescribing, dispensing, monitoring and administration of medicines to children.

    £59.95Buy now
  • Nutraceuticals


    This authoritative text assesses the medical and scientific evidence for the use of nutraceuticals. Includes monographs on 25 nutraceuticals such as soy and tea.

    £38.00Buy now
  • Complementary and Alternative Medicine

    Complementary and Alternative Medicine

    A practical reference source on alternative and complementary therapies. Enables healthcare professionals to give knowledge-based advice.

    £43.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Whispering (Alba/

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.